| Serial Number | 79221610 |
| Word Mark | KHPG |
| Filing Date | Wednesday, September 13, 2017 |
| Status | 709 - CANCELLED - SECTION 71 |
| Status Date | Friday, May 30, 2025 |
| Registration Number | 5603711 |
| Registration Date | Tuesday, November 13, 2018 |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, August 28, 2018 |
| Description of Mark | The mark consists of a stylized wording "KHPG". |
| Goods and Services | Medicines for humans for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, stomach, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; medicines for humans to treat or prevent diabetes, coughs, colds, influenza, headaches and allergic reactions; anti-infectives; anti-inflammatories; vaccines; pharmaceutical preparations used for the relief of pain and to reduce fever; pharmaceutical preparations and substances for the prevention and/or treatment of cardiovascular diseases, hemophilia, metabolic diseases, cancer, multiple sclerosis, urologic diseases, sexual dysfunction, osteoporosis, and climacteric diseases; pharmaceutical preparations, namely, anticoagulants and platelet aggregation inhibitors; contraceptive preparations, analgesics, anti-pyretics, anti-inflammatory preparations, anti-septic preparations, medicated lip balm, anesthetic spray for topical use, astringents, pediculicides, decongestants, antifungal agents, anti-infective pharmaceutical preparations, antacids, cold preparations in the nature of preparations for treating colds, menstrual symptom treatment preparations and dermatologicals; vitamin and mineral supplements; calcium supplements; pharmaceutical preparations, namely, ophthalmics; pharmaceutical preparations for the treatment of ophthalmic diseases and conditions; crude drugs for the treatment of central nervous system diseases, namely, hypertension, hyperlipidemia, schizophrenia and melancholia, digestive system diseases, namely, dyspepsia, chronic gastritis, chronic lithogenous cholecystitis, chronic cholecystitis and gall-stone, ophthalmology system diseases, namely, wet Age-related Macular Degeneration (AMD), and other diseases, namely, fever, irritability, red eyes, mouth sores, sore throat, swollen gums, constipation, pharyngitis, tonsillitis, gingivitis, upper respiratory infection (URI), acute bronchitis, diabetes and nephropathy ; Chinese patent medicine for the treatment of central nervous system diseases, namely, hypertension, hyperlipidemia, schizophrenia and melancholia, digestive system diseases, namely, dyspepsia, chronic gastritis, chronic lithogenous cholecystitis, chronic cholecystitis and gall-stone, ophthalmology system diseases, namely, wet Age-related Macular Degeneration (AMD), and other diseases, namely, fever, irritability, red eyes, mouth sores, sore throat, swollen gums, constipation, pharyngitis, tonsillitis, gingivitis, upper respiratory infection (URI), acute bronchitis, diabetes and nephropathy ; biochemical medicines for the treatment of cancer; radioactive medicines for the treatment of cancer; gases for medical purposes; disinfectants; solutions for contact lenses; dietetic substances adapted for medical use; food for babies; depuratives; pesticides; disinfectant wipes impregnated with disinfecting compounds; medical wound dressings; teeth filling materials |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, May 30, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Chengdu Kanghong Pharmaceuticals Group Co., Ltd. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | CN |
| Party Name | Chengdu Kanghong Pharmaceuticals Group Co., Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | CN |
| Party Name | Chengdu Kanghong Pharmaceuticals Group Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | CN |
| Event Date | Event Description |
| Thursday, November 23, 2017 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Thursday, December 7, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, December 12, 2017 | APPLICATION FILING RECEIPT MAILED |
| Monday, December 18, 2017 | NON-FINAL ACTION WRITTEN |
| Tuesday, December 19, 2017 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, January 9, 2018 | REFUSAL PROCESSED BY MPU |
| Thursday, July 5, 2018 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, July 18, 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, July 18, 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, July 18, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, August 8, 2018 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, August 8, 2018 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, August 8, 2018 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Friday, August 24, 2018 | NOTIFICATION PROCESSED BY IB |
| Tuesday, August 28, 2018 | PUBLISHED FOR OPPOSITION |
| Tuesday, August 28, 2018 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, November 13, 2018 | REGISTERED-PRINCIPAL REGISTER |
| Wednesday, February 13, 2019 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Thursday, February 21, 2019 | GENERIC MADRID TRANSACTION CREATED |
| Saturday, December 16, 2017 | ASSIGNED TO EXAMINER |
| Tuesday, January 9, 2018 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Saturday, January 27, 2018 | REFUSAL PROCESSED BY IB |
| Tuesday, July 17, 2018 | ASSIGNED TO LIE |
| Thursday, February 21, 2019 | GENERIC MADRID TRANSACTION SENT TO IB |
| Thursday, February 10, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, February 10, 2022 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Thursday, February 10, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, February 10, 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Friday, April 19, 2019 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Thursday, February 10, 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Thursday, February 10, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, November 13, 2023 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| Friday, May 30, 2025 | CANCELLED SECTION 71 |
| Sunday, June 9, 2024 | NEW REPRESENTATIVE AT IB RECEIVED |